Business Context and Reporting Period
This Form 8-K Current Report from Ocular Therapeutix, Inc. (OCUL) covers events occurring on June 16, 2022, specifically the company's 2022 Annual Meeting of Stockholders. The filing details corporate governance actions, including director elections, executive compensation votes, and amendments to equity incentive plans.
Key Financial Metrics
This filing is a current report regarding corporate governance and does not contain financial performance data. Consequently, there are no reported values for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes and Corporate Actions
- Stock Incentive Plan Amendment: Stockholders approved an amendment to the 2021 Stock Incentive Plan, increasing the number of shares available for issuance by 3,600,000 shares.
- Director Elections: Stockholders elected Seung Suh Hong, Ph.D., Richard L. Lindstrom, M.D., and Leslie J. Williams as Class II directors to serve until the 2025 Annual Meeting.
- Executive Compensation: Stockholders approved a non-binding advisory proposal regarding the compensation of named executive officers.
- Auditor Ratification: Stockholders ratified the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2022.
Voting Results Summary
| Proposal | Votes For | Votes Against/Withheld | Abstain | Broker Non-Votes |
|---|---|---|---|---|
| Election of Seung Suh Hong, Ph.D. | 34,100,452 | 7,981,093 (Withheld) | N/A | 18,607,745 |
| Election of Richard L. Lindstrom, M.D. | 31,374,926 | 10,706,619 (Withheld) | N/A | 18,607,745 |
| Election of Leslie J. Williams | 34,258,074 | 7,823,471 (Withheld) | N/A | 18,607,745 |
| Executive Compensation (Say-on-Pay) | 31,197,580 | 10,723,248 | 160,717 | 18,607,745 |
| Stock Incentive Plan Amendment | 33,298,660 | 8,728,155 | 54,730 | 18,607,745 |
| Auditor Ratification | 60,017,922 | 319,015 | 352,353 | 0 |
Guidance, Outlook, and Risks
This filing does not provide financial guidance, management commentary on future outlook, or specific risk factors. It strictly reports on the outcomes of the stockholder vote.
Key Facts for Investor Verification
- Verify the impact of the 3,600,000 share increase to the 2021 Stock Incentive Plan on potential future dilution.
- Note the significant number of Broker Non-Votes (18,607,745) across all proposals, indicating a large portion of shares held in street name where brokers lacked discretionary voting power.
- Review the definitive proxy statement filed on May 2, 2022, for detailed terms of the Stock Incentive Plan Amendment referenced in Exhibit 99.1.
- Confirm the tenure of the newly elected Class II directors, which extends through the 2025 Annual Meeting.